Singapore: Mr Xu Hang has resigned from the position of co-chief executive officer (co-CEO) at Mindray Medical Internati...
Singapore: ProMetic Life Sciences has finalized the $10 million strategic equity investment by Shenzhen Hepalink Pharma...
Singapore: Recognizing the region's need to work towards self-sufficiency in plasma products, Bioplasma World Asia 2012 ...
Singapore: Chugai Pharmaceutical and Debiopharm Group entered into a licensing agreement regarding FF284 (called Debio ...
Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Part...
Singapore: US-based Medistem has entered into a collaboration with Superview Biotechnology, a subsidiary of Yinhuan Hold...
Singapore: China Health Resource Incorporation (CHRI) issued a final termsheet to Herborium Group and is now awaiting re...
Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, held its 2012 annual general meet...
Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in cert...
Singapore: National Health and Family Planning Commission, China, has notified the WHO of two additional laboratory-conf...
Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible...
Singapore: Boehringer Ingelheim China's prescription medicine business has outperformed the market with a growth rate of...
Singapore: Herbalife received eight licenses by China's Ministry of Commerce to conduct its direct-selling business in H...
Singapore: Hangzhou Jiuzhou Grand Pharmacy Chain, subsidiary of China Jo-Jo Drugstores, has signed a sales incentive agr...
Singapore: Aetna, a global diversified healthcare benefits company, and Starr International Insurance have formed a stra...
Singapore: Concluding an elaborate probe that started late last year, China has now said that the hepatitis B vaccines w...
Two separate but equally important developments took place in China this month. One, intensification of investigations i...
Singapore: British drugmaker GlaxoSmithKline that has been facing bribery allegations in China has now said that its for...
